Oruka Therapeutics, Inc. (ORKA)
Healthcare
Biotechnology
94.80 $
-1.8%
vs. previous close
Closing price · As of: 3. Aug 2026
Oruka Therapeutics, Inc. (ORKA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -24 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 21 | Q4 21 | Q1 22 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.9 | -4.9 | -4.3 | -0.2 | -2.6 | -35 | -19 | -21 | -23 | -22 | -23 | -24 | -91 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| – | – | – | 0.1 | 0.7 | – | – | 4.9 | 5.1 | 10 | 4.1 | 7.0 | 26 | |
| -0.3 | 0.6 | -1.2 | 6.8 | -0.1 | 7.3 | 4.0 | -3.0 | -2.3 | -0.6 | 3.4 | 1.5 | 2.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.3 | |
| 0.0 | 0.0 | 0.0 | – | – | -0.2 | -330 | 43 | 4.9 | -122 | -22 | -14 | -154 | |
| – | – | – | – | 0.0 | – | – | 0.0 | 0.0 | 0.0 | 0.0 | – | – | |
| – | – | – | 28 | 0.0 | 450 | -0.5 | 0.0 | 0.1 | 170 | 0.3 | 41 | 211 | |
| -4.9 | -5.0 | -4.3 | 28 | -2.6 | 378 | -349 | 22 | -18 | 26 | -44 | 2.6 | -34 | |
| -4.9 | -5.0 | -4.3 | -0.2 | -2.6 | -35 | -19 | -21 | -23 | -22 | -23 | -24 | -91 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.